SCHEMBL10967773

SCHEMBL10967773

CC(=O)Nc1ccc(Cl)c2c1CCN(C)CC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 3/20 0.46
ADRA2B P18089 3/20 0.46
ADRA2C P18825 3/20 0.46
ADRA1D P25100 2/20 0.46
ADRA1A P35348 2/20 0.46
ADRA1B P35368 2/20 0.46
CYP2D6 P10635 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NOTUM Q6P988 2/20 0.40
POLB P06746 1/20 0.40
ABL1 P00519 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13731847 0.84 NISCH (0.47) CA1CA2CA9POLBALDH1A1
SCHEMBL6784937 0.81 CA1 (0.44) CA1CA2CA9SMN1; SMN2POLB
SCHEMBL8152134 0.77 RXFP1 (0.44) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL6784074 0.75 KDM4E (0.42) POLBALDH1A1NPC1RAB9A
SCHEMBL6784777 0.75 NPC1 (0.51) LMNASMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL6785452 0.74 RXFP1 (0.44) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL9548521 0.73 ADRA2A (0.59) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL6610930 0.72 NPC1 (0.40) LMNASMN1; SMN2POLBALDH1A1NPC1
SCHEMBL8910486 0.72 ADRA2A (0.55) ADRA2AADRA2BADRA2CADRA1DADRA1A
SCHEMBL8807579 0.72 UHRF1 (0.35) LMNAPOLBALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-B1 6-CHLORO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE, ITS ACID ADDITION SALTS AND ITS USE AS AN INTERMEDIATE SMITHKLINE BECKMAN CORPORATION (US) 1986-04-09 EP disclosed
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 EP disclosed